Cite
HARVARD Citation
Pruis, S. et al. (2019). Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore. International journal of technology assessment in health care. pp. 126-133. [Online].